StopDrops delivers an all natural nicotine free mint and cherry flavored lozenge cessation that will aid an individual in stopping smoking and reducing a desire for nicotine.
StopDrops key active ingredients have been medically and scientifically proven and test as follows:
St. John’s Wort for Tobacco Cessation
This study has been completed. First Received on November 29, 2006. Last Updated on April 15, 2011 History of Changes.
Sponsor: Mayo Clinic
Collaborator: National Cancer Institute (NCI)
Information provided by: Mayo Clinic
ClinicalTrials.gov Identifier: NCT00405912
After a steady decline for the last 50 years, the prevalence of tobacco use in the United States has reached a plateau of approximately 23%. Currently available treatments among adults are expensive and not efficacious for all tobacco users. New pharmacologic agents need to be developed and tested to achieve the Healthy People 2010 goal of less than a 12% adult tobacco use prevalence.
Bupropion, an FDA approved agent for tobacco cessation, acts by inhibiting central synaptic repute of dopamine and norepinephrine. A widely used herbal antidepressant, St. John’s Wort (SJW), shares a similar mechanism of action and is effective for treating mild to moderate depression. SJW is well tolerated, available over the counter, and is significantly less expensive than the established treatments for tobacco dependence.
StopDrops is ready for manufacturing and placement in excess of 45,000 retail locations throughout the US. The NRT (Nicotine Replacement Therapy) market is expected to reach $22 Billion US by 2024. Published Medical Data suggests that consuming products that contain nicotine can cause cancer. StopDrops is the only nicotine free smoking cessation that will available at retail locations including but not limited too: CVS, Walgreens, Walmart and Duane Reade.